Company Analysis ГЕНЕТИКО
1. Summary
Advantages
- Price (25.89 ₽) is less than fair price (41.87 ₽)
Disadvantages
- Dividends (0%) are below the sector average (4.53%).
- The stock's return over the last year (-25.26%) is lower than the sector average (-3%).
- The company's current efficiency (ROE=0%) is lower than the sector average (ROE=33.89%)
2. Share price and performance
2.1. Share price
2.3. Market efficiency
ГЕНЕТИКО | Потреб | Index | |
---|---|---|---|
7 days | 2.8% | 5.2% | 2.5% |
90 days | -5.8% | -3.4% | -1.6% |
1 year | -25.3% | -3% | -6.6% |
GECO vs Sector: ГЕНЕТИКО has significantly underperformed the "Потреб" sector by -22.26% over the past year.
GECO vs Market: ГЕНЕТИКО has significantly underperformed the market by -18.68% over the past year.
Stable price: GECO is not significantly more volatile than the rest of the market on "Московская биржа" over the last 3 months, with typical variations of +/- 5% per week.
Long period: GECO with weekly volatility of -0.4858% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (25.89 ₽) is lower than the fair price (41.87 ₽).
Price significantly below the fair price: The current price (25.89 ₽) is 61.7% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (21.62).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (5.6).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0) is lower than that of the sector as a whole (6.89).
P/BV vs Market: The company's P/BV (0) is lower than that of the market as a whole (1.33).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (1.47).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (1.05).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (5.08).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (1.57).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-20%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-14.13%).
5.4. ROE
ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (33.89%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (14.32%).
5.5. ROA
ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (16.85%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (7.71%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.31%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (18.47%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '4.53%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
9. Stocks forum ГЕНЕТИКО
9.2. Latest Blogs
Что-то писать одно и то же, пока рынок в боковике, уже надоедает, можете сегодня почитать анекдот 😂
В школе на уроке математики учительница спрашивает:
- Машенька, кем работает твой папа?
- Мой папа - инженер.
- Сколько он зарабатывает?
- 12 тысяч рублей.
- А мама?
- Мама - учительница. Зарабатывает 5,5 тысячи рублей.
- Каким получается бюджет вашей семьи?
- 17,5 тысячи рублей....
More
💊 Слыхали про супер-лекарство от наших фарм-компаний?
- ❌ Нет ?
Да я тоже нет, но судя по темпам роста , - оно есть.
🦠 Что там за напасть в Китае (где ж ещё опять) ?
Метапневмовирус - является одним из возбудителей респираторных инфекций, был открыт аж в в 2001 году.
Чаще всего вызывает острые респираторные инфекции, включая бронхиолит, пневмонию....
More
🤔 Интересно наблюдать как изменились цены компаний после выхода на ipo
Вот плюсовые из них
#GECO #geco +68%
#ASTR #astr +7%
#SVCB #svcb +7%
#UGLD #ugld +15%
#DIAS #dias +3%
#POSI #posi +200%
данные на 06.11.24
Статье лайк 👍 если пост был для вас полезным
Подписывайтесь 🖖 будем и дальше анализировать потенциал компаний.
Есть интересные идеи 💡
More
All blogs ⇨